Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
Net Issuance of Debt
Fuji Pharma Co Ltd
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fuji Pharma Co Ltd
TSE:4554
|
Net Issuance of Debt
¥2.8B
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-4%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Issuance of Debt
¥61.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-55%
|
CAGR 10-Years
-13%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Issuance of Debt
-¥56.5B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Net Issuance of Debt
-¥22.9B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-72%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Issuance of Debt
-¥7.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
Astellas Pharma Inc
TSE:4503
|
Net Issuance of Debt
¥758B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fuji Pharma Co Ltd's Net Issuance of Debt?
Net Issuance of Debt
2.8B
JPY
Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's Net Issuance of Debt amounts to 2.8B JPY.
What is Fuji Pharma Co Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 10Y
-4%
Over the last year, the Net Issuance of Debt growth was -52%. The average annual Net Issuance of Debt growth rates for Fuji Pharma Co Ltd have been 28% over the past three years , and -4% over the past ten years .